Investing Ideas
/
Norwegian Healthcare Undervalued over 20% based on DCF

Norwegian Healthcare Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Gentian Diagnostics

Market Cap: NOK 879.1m

Develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe.

GENT

NOK 57.00

0.9%